City

Houston (3)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Baylor College of Medicine (2)

Tarix Pharmaceuticals (1)

Collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine (2)

Constant Therapeutics LLC (1)

The Methodist Hospital Research Institute (1)

Intervention

ara-c (1)

campath-1h (1)

cyclophosphamide (1)

stem cell infusion (1)

taa-specific ctls (1)

total body irradiation (1)

txa127 1000 mcg/kg/day (1)

txa127 300 mcg/kg/day (1)

Study Documents

Intervention Type

biological (2)

drug (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Non Hodgkins Lymphoma

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting

Hodgkins Lymphoma
Non Hodgkins Lymphoma

TAA-specific CTLs

Houston, Texas

Texas Children's Hospital

Jul 14, 2022

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated

Double Cord Blood Transplant
+8 more

TXA127 300 mcg/kg/day
TXA127 1000 mcg/kg/day

Houston, Texas

MD Anderson Cancer Center

Dec 7, 2020

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed

Has Results

Acute Lymphoblastic Leukemia
+8 more

Ara-C
+4 more

Houston, Texas
+1 more

Jan 15, 2020